Mounjaro online: doses, cost and the savings card, explained
The FDA approved Mounjaro to treat type 2 diabetes. It is not approved for weight loss. A licensed Zealthy provider can review your health history online, then advise whether Mounjaro, Zepbound® or something else suits you.
- One injection a week of tirzepatide, which acts on GIP and GLP-1 receptors
- When your plan covers brand Mounjaro, the copay can be as low as $25/mo*
- Intake reviewed online. No live appointment needed to start
- Open to eligible adults in all 50 states
Mounjaro has a boxed warning. Read the important safety information.
Is Mounjaro approved for weight loss?
No. The FDA approved Mounjaro in May 2022 for blood sugar control in type 2 diabetes.1 Weight management is not on its label. The tirzepatide product approved for that is Zepbound.
What are the Mounjaro doses?
Six strengths: 2.5, 5, 7.5, 10, 12.5 and 15 mg, injected once a week. You start at 2.5 mg, and the dose rises only when your blood sugar calls for it.2 See the dose schedule.
Who can use the Mounjaro savings card?
People with commercial insurance and a prescription for an approved use, meaning type 2 diabetes. Government insurance is excluded.3 See the savings card rules.
*Copays are set by your plan, and coverage is not guaranteed. $25 is the lowest price under Eli Lilly’s Mounjaro Savings Card, which requires covered commercial insurance and an on-label prescription. Active Zealthy membership required. †$329 a month, or from $216 a month on a 3-month supply. No compounded medication is FDA-approved, and the FDA does not review these products for safety, effectiveness or quality. Membership ($39 in month one, $135 monthly after) is separate.
Safety summary: Mounjaro carries a boxed warning about possible thyroid tumors. It is not for anyone whose own or family history includes medullary thyroid carcinoma, or for people with Multiple Endocrine Neoplasia syndrome type 2. Read the full safety information.
In a 72-week trial, adults with type 2 diabetes lost an average of 14.7% of their weight on tirzepatide 15 mg
The trial, SURMOUNT-2, gave 938 adults with type 2 diabetes and a BMI of 27 or higher weekly tirzepatide 10 mg, 15 mg or placebo. After 72 weeks, people had lost 12.8% of their weight on average with 10 mg, 14.7% with 15 mg and 3.2% with placebo.4 Mounjaro is the same drug, approved for blood sugar: in a 40-week study, A1C fell by 2.0 to 2.3 points.2
This is arithmetic on one trial’s averages, not a forecast for you. Everyone in the trial had type 2 diabetes and received diet and activity counseling, and results varied.5 Mounjaro is not approved for weight loss.
What Mounjaro is, and how it differs from Zepbound
Mounjaro is Eli Lilly’s weekly tirzepatide injection for type 2 diabetes. Zepbound is the same drug approved for weight management. Compounded tirzepatide is neither.
| Feature | Brand MounjaroThe diabetes label | Brand ZepboundThe weight management label | Compounded tirzepatideNot a brand product |
|---|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide | Tirzepatide, made by a compounding pharmacy |
| FDA-approved for | Type 2 diabetes from age 10, and cardiovascular risk in adults with type 2 diabetes2 | Weight reduction in adults, and sleep apnea in adults who have obesity5 | Not FDA-approved. The FDA does not review it for safety, effectiveness or quality6 |
| Approved for weight loss | No | Yes | No |
| Where it is filled | Your own pharmacy | Your own pharmacy | Shipped from a partner pharmacy |
| Medication cost through Zealthy | Plan copay, as low as $25/mo when covered | Plan copay, as low as $25/mo when covered | $329/mo, or from $216/mo on a 3-month supply |
| Zealthy membership | $39 in month one, then $135 monthly. Medication not included. | ||
How Mounjaro works
Tirzepatide is a single molecule that activates two receptors, GIP and GLP-1. It prompts the pancreas to release insulin when blood sugar is high, lowers the hormone glucagon, slows stomach emptying and reduces how much people eat. Its half-life of about five days is what allows once-weekly dosing.2
Mounjaro vs Zepbound: one drug, two labels
Each is Eli Lilly’s tirzepatide, sold in six identical strengths under an identical boxed warning. The differences are the approved uses, the dosing rules, the savings cards and the prices. Zepbound’s label requires a step up to at least 5 mg, while Mounjaro’s raises the dose only as blood sugar requires.5 Our Zepbound page covers the weight management side.
Mounjaro for weight loss, in short
- People in Mounjaro’s diabetes trials lost weight, but the FDA has not approved it for that purpose. Prescribing it for weight loss alone is off-label.2
- Plans have generally covered GLP-1 drugs for diabetes. In KFF’s 2026 survey, 18% of employers with 200 or more workers covered them mainly for weight loss.7
- The savings card from Lilly only applies to on-label prescriptions.3
- Without type 2 diabetes, expect your provider to discuss Zepbound first.
Mounjaro trial results for blood sugar, weight and the heart
In its main trials Mounjaro lowered A1C by about 1.7 to 2.4 points and reduced weight at every dose. Eli Lilly funded all of them.
| Trial | Who was studied | Compared with | Result on tirzepatide |
|---|---|---|---|
| SURPASS-1 | 478 adults with type 2 diabetes on no other diabetes drug, 40 weeks | Placebo | A1C down 1.7 to 1.8 points (placebo 0.1). Weight down 6.3 to 7.8 kg (placebo 1.0 kg).2 |
| SURPASS-2 | 1,879 adults on metformin, 40 weeks | Semaglutide 1 mg, the drug in Ozempic® | A1C down 2.0 to 2.3 points (semaglutide 1.9). Weight down 7.6 to 11.2 kg (semaglutide 5.7 kg).8 |
| SURPASS-5 | 475 adults on basal insulin, 40 weeks | Placebo | A1C down 2.1 to 2.4 points (placebo 0.9). Weight down 5.4 to 8.8 kg (placebo gained 1.6 kg).2 |
| SURMOUNT-2 | 938 adults with type 2 diabetes and a BMI of 27 or more, 72 weeks | Placebo | Weight down 12.8% (10 mg) and 14.7% (15 mg), against 3.2% for placebo.4 |
| SURPASS-CVOT | 13,299 adults with type 2 diabetes and cardiovascular disease, about four years | Dulaglutide 1.5 mg | Cardiovascular death, heart attack or stroke in 12.2% versus 13.1%. Tirzepatide was no worse, but not proven better.9 |
A1C is the blood sugar measure used in diabetes trials. Figures are average changes from the start of each trial. Individual results vary.
Mounjaro weight loss results in context
In Mounjaro’s diabetes trials, average weight loss ranged from 5.4 to 11.3 kg (about 12 to 25 lb), depending on dose and study.2 The larger percentages quoted for tirzepatide come from people without diabetes: 15.0% to 20.9% over 72 weeks in SURMOUNT-1, against 3.1% on placebo.10 For the comparison with semaglutide, see Mounjaro vs Ozempic.
How to get Mounjaro online through Zealthy
You answer health questions, a licensed provider reviews them, and our team deals with your insurer. A live call is optional.
1. Join and complete the intake
Membership is $39 for the first month. The intake covers your health history, medications and goals. Say whether you have type 2 diabetes, because that decides which tirzepatide brand is on-label for you.

2. A provider reads your intake
A U.S.-licensed physician or nurse practitioner reviews your intake online and decides whether a GLP-1 medication is appropriate, and which one. No live appointment is needed to start.

3. We handle the prior authorization
For brand-name medication, our insurance coordination team submits the prior authorization. When your plan covers it, the copay can be as low as $25 a month. Approval is the plan’s decision.

4. Your prescription is filled
Brand-name prescriptions go to your own pharmacy. Compounded tirzepatide, if prescribed, ships from a partner pharmacy and usually arrives within 2 to 9 business days. It is not Mounjaro and not FDA-approved.

5. Stay in touch as your dose changes
Doses change no sooner than every four weeks. Message your care team about side effects at any time. A weight loss coach and optional video or phone visits are included.


What your Zealthy membership pays for
- A licensed provider’s review, and a prescription if one is appropriate
- An insurance coordination team that files prior authorizations for brand-name medication
- Unlimited secure messaging with your care team
- Monthly video or phone visits with a provider, if you want them
- A weight loss coach
- The Zealthy app on iOS and Android, and the online portal
Medication is not part of the membership and is paid for separately.
Get StartedMounjaro side effects and how common they are
Nausea is the most common Mounjaro side effect, reported by 12% to 18% of adults in placebo-controlled trials, against 4% on placebo. Most side effects involve the stomach and gut.
| Side effect | 5 mg | 10 mg | 15 mg | Placebo |
|---|---|---|---|---|
| Nausea | 12% | 15% | 18% | 4% |
| Diarrhea | 12% | 13% | 17% | 9% |
| Decreased appetite | 5% | 10% | 11% | 1% |
| Vomiting | 5% | 5% | 9% | 2% |
| Constipation | 6% | 6% | 7% | 1% |
| Indigestion | 8% | 8% | 5% | 3% |
| Abdominal pain | 6% | 5% | 5% | 4% |
Adults reporting each reaction in two pooled placebo-controlled trials. These are the reactions the label lists at 5% or higher.2
Ways to ease side effects
- Report symptoms early. The label never forces an increase, so your provider can hold your dose.
- Drink fluids if you are vomiting or have diarrhea. Dehydration can harm the kidneys.11
- On insulin or a sulfonylurea? Ask whether that dose should come down.
- On birth control pills? Add backup contraception for the 4 weeks following your first dose and every increase.
Get medical help right away for
- Severe stomach pain that will not go away, with or without vomiting
- A swollen face, lips, tongue or throat, or difficulty breathing
- Upper stomach pain with fever, yellow skin or eyes, or clay-colored stools
- Sudden changes in your vision
- A lump or swelling in the neck, or lasting hoarseness
How long Mounjaro side effects tend to last
Most nausea, vomiting and diarrhea in the trials happened while the dose was being raised, and became less frequent over time. Gut side effects led 3.0% to 6.6% of people to stop treatment, against 0.4% on placebo.2
Other side effects and low blood sugar
Injection site reactions affected 3.2% of people, against 0.4% on placebo. Burping, gas, reflux and bloating each showed up in roughly 3% of people or fewer. Mounjaro alone rarely caused low blood sugar. With basal insulin, 14% to 19% had a reading under 54 mg/dL, against 13% on placebo.2
Why Mounjaro’s rates look lower than Zepbound’s
Zepbound’s label reports nausea in 25% to 29% of adults, though the drug is identical.5 The figures come from different trials in different people, and the labels caution against comparing rates across trials.
Serious risks and who should not take Mounjaro
Mounjaro’s boxed warning concerns thyroid C-cell tumors. People whose own or family history includes medullary thyroid carcinoma should not take it. Neither should people with Multiple Endocrine Neoplasia syndrome type 2, or people with a past serious allergic reaction to tirzepatide. The label also warns about pancreatitis, kidney injury from dehydration, severe stomach problems, gallbladder disease and worsening diabetic eye disease.2
On November 9, 2026, the FDA said GLP-1 labels must add a warning about a possible increased risk of NAION, a rare cause of sudden vision loss.12 See the full safety information and our GLP-1 side effects guide.
Mounjaro doses and dosing schedule
Mounjaro dosing starts at 2.5 mg once a week. The dose can then go up in 2.5 mg steps, each after four weeks or more on the current dose, if more blood sugar control is needed. The maximum is 15 mg for adults and 10 mg for ages 10 to 17.
| Weekly dose | Earliest start | Notes |
|---|---|---|
| 2.5 mg | Week 1 | Starting dose for everyone. |
| 5 mg | Week 5 | First step up, if needed. |
| 7.5 mg | Week 9 | If more blood sugar control is needed. |
| 10 mg | Week 13 | Top dose for patients under 18. |
| 12.5 mg | Week 17 | For adults. |
| 15 mg | Week 21 | Maximum for adults. |
- 2.5 mgStarting dose
- 5 mgIf needed
- 7.5 mgIf needed
- 10 mgAges 10 to 17 maximum
- 12.5 mgIf needed
- 15 mgAdult maximum
Weeks show the fastest schedule the prescribing information allows.2 Many people stay longer on a dose or never reach 15 mg.
What changed in Mounjaro dosing in 2026
The label revised in August 2026 no longer moves everyone to 5 mg after four weeks. Increases now depend on blood sugar.2 Zepbound still requires the step to 5 mg.5 Mounjaro doses are not based on body weight and need no adjustment for kidney or liver impairment.
How to take Mounjaro
- Weekly, at whatever time suits you, with a meal or without.
- Inject under the skin of the abdomen or thigh. The back of the upper arm is for when someone else injects.
- Rotate the site each week. Never mix it with insulin.2
If you miss a dose
- Within 4 days (96 hours): take it as soon as you can.
- After 4 days: skip it and resume on your usual day.
- Keep at least 3 days (72 hours) between any two doses.11
Pens and storage
- A single-dose pen holds one dose. A carton holds four.
- Keep refrigerated (36°F to 46°F) inside the carton. Do not freeze.
- A single-dose pen can stay at up to 86°F for 21 days in total.2
The label also lists single-dose vials, a four-dose vial and a four-dose KwikPen, which has its own 30-day storage rule. LillyDirect sells only the single-dose pen.13 For compounded vials, see tirzepatide dosing in units.
Mounjaro cost, savings card and coupon rules
Mounjaro can cost $25 a fill when a commercial plan covers it and you use Lilly’s savings card. Without coverage it starts at $499 a month. The list price is $1,112.16 per fill.
| Your situation | What you may pay | Details |
|---|---|---|
| Commercial plan covers Mounjaro | As little as $25 per fill | With the Mounjaro Savings Card and an on-label prescription.3 |
| Commercial plan does not cover it | As low as $499 a month | Savings card price for an on-label prescription.3 |
| No insurance | From $499 a month | LillyDirect self-pay price for the single-dose pen, any strength. Taxes and fees may apply.13 |
| Medicare or Medicaid | Set by your plan | No savings card. By Lilly’s count, roughly 8 of every 10 Part D enrollees spend $0 to $50 per 28 days.3 |
| List price | $1,112.16 per fill | Lilly’s published price for four pens, as of November 2026.14 |
Lilly sets these prices and can change them. The current savings card expires December 31, 2026.
How much does Mounjaro cost with insurance?
With insurance you pay your plan’s copay, minus any savings card you qualify for. Plans have generally covered GLP-1 medications for diabetes.7 Many require a prior authorization, and Zealthy’s coordination team submits it. When your plan covers the medication, the copay can be as low as $25 a month.
How much does Mounjaro cost without insurance?
Without insurance, Mounjaro starts at $499 a month through LillyDirect, at every strength.13 You still need a prescription. If you are paying cash for weight management, compare Zepbound, whose self-pay prices start at $299.15
Mounjaro savings card: what it does
Eli Lilly runs the Mounjaro Savings Card. It is a copay card and the only manufacturer coupon for Mounjaro. There are two levels of savings, and yours turns on whether your commercial plan covers the drug.3
| Card terms | Plan covers Mounjaro | Plan does not cover it |
|---|---|---|
| Lowest price | $25 per fill | $499 per fill |
| Fill length | 28, 56 or 84 days | 28 days |
| Per-fill cap | $150, $300 or $450 | $647 |
| Fills allowed each year | 13 | 13 |
| Yearly cap | $1,950 | $8,411 |
| Card ends | Dec. 31, 2026 | Dec. 31, 2026 |
The card pays $150 at most toward a one-month fill. If your copay is $175 or less you pay $25. Above that, you pay the difference: a $250 copay leaves $100. A three-month fill can cost $25 in total, if your plan and pharmacy allow one.
Who can use the Mounjaro savings card
You must meet every condition at each fill.3
- Your prescription is for the single-dose pen and for a use on Mounjaro’s label. All of those involve type 2 diabetes.
- You have commercial drug insurance. The card does not work for people with no insurance.
- You have no government coverage, such as Medicare, Medicaid, TRICARE, VA or a state drug program.
- You are 18 or over and a U.S. or Puerto Rico resident.
- You are not combining it with another coupon or discount card for Mounjaro.
To get one, select “Get Savings Card” on Lilly’s Mounjaro savings page, answer the eligibility questions and activate the card before your first fill.
Mounjaro with Medicare or Medicaid
The savings card cannot be used with government insurance, but coverage is a separate matter. Lilly says many Medicare Part D plans pay for Mounjaro when it treats type 2 diabetes.3 Medicaid programs must cover GLP-1 medications for diabetes.16 The Medicare GLP-1 Bridge is for weight management and does not include Mounjaro.17
What you pay through Zealthy
- Membership: $39 the first month and $135 each month after. Medication is separate.
- Brand Mounjaro or Zepbound through insurance: we submit the prior authorization. When your plan covers it, the copay can be as low as $25 a month at your own pharmacy.
- Compounded tirzepatide: $329 a month, or from $216 a month on a 3-month supply, shipping included.
Compounded tirzepatide is not Mounjaro and is not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality, and says they should be used only when an approved drug cannot meet a patient’s needs.6 A Zealthy provider prescribes it only when appropriate for you.
Mounjaro for weight loss without diabetes? Coverage is unlikely and the savings card will not apply. Zepbound is the on-label choice. Check your plan with the GLP-1 insurance checker, or see tirzepatide near me.
LillyDirect fills Mounjaro prescriptions. It does not write them.
LillyDirect is Eli Lilly’s own pharmacy channel. It sells the Mounjaro single-dose pen for self-pay from $499 a month once a licensed provider sends in a prescription.13
| Feature | Zealthy | LillyDirect |
|---|---|---|
| What it is | Telehealth program with U.S.-licensed providers | The manufacturer’s pharmacy service |
| Prescribes | Yes, when a provider finds it appropriate | No. It needs a prescription from your provider |
| Insurance for Mounjaro | We submit the prior authorization to your plan | Listed as self-pay |
| Price of Mounjaro | Your plan’s copay, as low as $25/mo when covered | From $499/mo |
| Ongoing care | Messaging, coaching and optional visits | Stays with your own prescriber |
LillyDirect details are from Lilly’s site as of November 2026. Zealthy is not affiliated with Eli Lilly or LillyDirect.
Mounjaro vs Zepbound, Ozempic, Wegovy and compounded tirzepatide
Zepbound and Wegovy® are approved for weight management. Mounjaro and Ozempic are approved for type 2 diabetes. Compounded tirzepatide is not FDA-approved.
| Feature | Mounjaro | Zepbound | Ozempic | Wegovy | Compounded tirzepatide |
|---|---|---|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide | Semaglutide | Semaglutide | Tirzepatide |
| Acts on | GIP and GLP-1 | GIP and GLP-1 | GLP-1 | GLP-1 | GIP and GLP-1 |
| FDA-approved for | Type 2 diabetes2 | Weight management, sleep apnea5 | Type 2 diabetes18 | Weight management19 | Not FDA-approved |
| Weekly dose range | 2.5 to 15 mg | 2.5 to 15 mg | 0.25 to 2 mg | 0.25 to 7.2 mg | Set by your provider |
| Average weight loss in a key trial | 12.8% to 14.7% in 72 weeks, with diabetes4 | 15.0% to 20.9% in 72 weeks, without diabetes10 | 5.7 kg in 40 weeks at 1 mg, with diabetes8 | 14.9% in 68 weeks at 2.4 mg, without diabetes20 | Not studied in these trials |
| Maker’s self-pay price | From $499/mo13 | From $299/mo for the KwikPen15 | $349/mo, or $499/mo for the 2 mg pen21 | $349/mo for the pen up to 2.4 mg22 | Zealthy: $329/mo, or from $216/mo on a 3-month supply |
Prices as of November 2026. Trial results come from separate studies and are not head-to-head comparisons. Results from brand-name trials should not be assumed for compounded tirzepatide, which is not FDA-approved.
What Zealthy members say about their care
One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
I started semaglutide at the recommendation of my Zealthy provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and Zealthy was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Since I started, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Individual results may vary. These are the experiences of Zealthy members and are not a guarantee of any outcome. Medication is prescribed only when a licensed provider finds it appropriate.

A licensed provider reads your history before any Mounjaro prescription
A U.S.-licensed physician or nurse practitioner checks your health history, including whether you have type 2 diabetes, before prescribing anything. If Mounjaro is the wrong medication for you, they will say so and explain the alternatives.
The medical information on this page is reviewed by the Zealthy care team against FDA prescribing information and published clinical trials. It is general education, not personal medical advice.
Mounjaro FAQs
Is Mounjaro approved for weight loss?
No. Its FDA approvals cover type 2 diabetes in adults and children 10 and older, plus lowering cardiovascular risk in adults with type 2 diabetes. A prescription for weight loss alone is off-label. Zepbound contains the same drug, tirzepatide, and is the version approved for weight management.
How much weight loss does Mounjaro cause?
It varies. In SURMOUNT-2, a 72-week trial in adults with type 2 diabetes, the average loss was 12.8% of body weight with tirzepatide 10 mg and 14.7% with 15 mg, against 3.2% with placebo. Mounjaro’s 40-week diabetes trials showed average losses of 5.4 to 11.2 kg. These are averages, not predictions.
What is the starting dose of Mounjaro?
The starting dose is 2.5 mg, injected once a week. When your blood sugar needs more help, the provider may increase it in 2.5 mg steps, once you have spent four weeks or more at your present dose. The dosing schedule shows the earliest week for each step.
What is the maximum Mounjaro dose?
Adults can go up to 15 mg weekly, and patients aged 10 to 17 stop at 10 mg weekly. Reaching 15 mg takes at least 20 weeks, because each 2.5 mg step lasts four weeks or longer. Many people never need the top dose.
I missed my Mounjaro injection. What now?
Inject it as soon as you can if no more than 4 days (96 hours) have passed since the missed dose. After 4 days, skip it and inject on your next regular day. Do not take two doses within 3 days (72 hours) of each other.
How much does Mounjaro cost without insurance?
Without insurance, Mounjaro starts at $499 a month through LillyDirect, Eli Lilly’s self-pay channel, for the single-dose pen at any strength. Lilly’s list price is $1,112.16 per fill of four pens. Both figures are as of November 2026, and a prescription is required either way.
What does the Mounjaro savings card take off the price?
Up to $150 for each month of medication. Eli Lilly issues it as a copay card. When commercial insurance covers Mounjaro, a fill of one, two or three months can drop to $25. Savings are capped at $1,950 a year and 13 fills, and the card ends on December 31, 2026.
Do I qualify for the Mounjaro savings card?
You qualify when four things are true: your prescription is for the single-dose Mounjaro pen and an on-label use, you carry commercial drug insurance, you are at least 18, and you are a U.S. or Puerto Rico resident. On-label always means type 2 diabetes, so a weight-loss-only prescription does not qualify.
Are there Mounjaro coupons besides the savings card?
Not from the manufacturer. Eli Lilly’s Mounjaro Savings Card is its only coupon, and the terms bar combining it with any other discount card or coupon for Mounjaro. Discount cards from other companies are separate products. We could not verify their prices, so we do not quote them.
Does the Mounjaro savings card work with Medicare or Medicaid?
No. Lilly’s terms exclude anyone enrolled in a government-funded program, including Medicare, Medicaid, TRICARE and VA coverage. Many Part D plans do pay for Mounjaro when it treats type 2 diabetes. By Lilly’s count, roughly 8 of every 10 Part D patients spend between $0 and $50 on a 28-day supply.
Does insurance cover Mounjaro for weight loss?
Usually not. Plans have generally covered GLP-1 medications for diabetes, and every approved use of Mounjaro involves type 2 diabetes. In KFF’s 2026 employer survey, 18% of firms with 200 or more workers covered GLP-1 drugs used mainly for weight loss. Zepbound or Wegovy is the more likely fit.
Which Mounjaro side effects happen most often?
Nausea and diarrhea lead the list, followed by decreased appetite, vomiting, constipation, indigestion and abdominal pain. In placebo-controlled trials, nausea was reported by 12% to 18% of adults depending on dose, against 4% on placebo. Most stomach side effects appeared while the dose was being raised and eased over time. See the side effect table.
Can I get a Mounjaro prescription online?
Yes, if a licensed provider finds it appropriate. With Zealthy you complete an online intake, and a U.S.-licensed physician or nurse practitioner reviews it. No live appointment is required to start. Brand-name prescriptions go to your own pharmacy, and our team submits the prior authorization to your plan.
Is compounded tirzepatide the same as Mounjaro?
No. Compounded tirzepatide is made by a compounding pharmacy. It is not Mounjaro, it is not FDA-approved, and the FDA does not review it for safety, effectiveness or quality. Mounjaro’s trial results should not be assumed for it. Through Zealthy it costs $329 a month, or from $216 a month on a 3-month supply.
What is the difference between Mounjaro and Zepbound?
The label. Each is Eli Lilly’s tirzepatide in six identical strengths. Mounjaro’s approval is for type 2 diabetes. Zepbound’s is for weight reduction in adults and for moderate to severe sleep apnea in adults who have obesity. Their savings cards, self-pay prices and insurance coverage also differ.
How is Mounjaro different from Ozempic?
They contain different drugs. Mounjaro is tirzepatide, which activates GIP and GLP-1 receptors. Ozempic is semaglutide, which activates GLP-1 only. Both are weekly injections approved for type 2 diabetes. In the SURPASS-2 trial, tirzepatide lowered A1C and weight more than semaglutide 1 mg. See Mounjaro vs Ozempic.
Does Mounjaro make birth control pills less effective?
It can. Tirzepatide slows stomach emptying, which may make birth control pills less effective. The label advises switching to a non-oral method, or adding a barrier method, during the 4 weeks after you start Mounjaro and the 4 weeks after any dose increase. Non-oral hormonal birth control should not be affected.
More on Mounjaro and tirzepatide
Important safety information
A summary of Mounjaro’s labeling. It does not replace the full prescribing information.
Boxed warning: risk of thyroid C-cell tumors
In rat studies, tirzepatide led to thyroid C-cell tumors. Nobody knows yet whether Mounjaro does the same in people, including a cancer called medullary thyroid carcinoma (MTC). Mounjaro is off limits if MTC has ever occurred in you or your family, and for people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Let your provider know right away about a neck lump or swelling, difficulty swallowing, breathlessness or hoarseness that lingers.2
Do not take Mounjaro if
- You or a close relative has ever had MTC, or you have MEN 2.
- Tirzepatide, or anything else in the product, has given you a serious allergic reaction.
Tell your provider before you start if you
- Have or have had pancreas problems.
- Have severe stomach problems, such as gastroparesis.
- Have a history of diabetic retinopathy.
- Are pregnant, breastfeeding, or planning either.
- Have surgery or another procedure coming up that uses anesthesia or deep sedation.
- Take insulin, a sulfonylurea or birth control pills.11
Possible serious side effects
- Pancreatitis: severe, persistent stomach pain, with or without vomiting, that may spread to the back.
- Hypoglycemia (low blood sugar), more likely alongside insulin or a sulfonylurea: dizziness, sweating, shakiness, confusion, fast heartbeat.
- Serious allergic reactions: a swollen face, lips, tongue or throat, difficulty breathing, severe rash.
- Kidney injury when vomiting or diarrhea causes dehydration.
- Severe stomach problems that do not go away.
- Vision changes.
- Gallbladder problems: upper stomach pain, fever, yellow skin or eyes, clay-colored stools.
- Food or liquid entering the lungs while under anesthesia or deep sedation.11
The FDA said on November 9, 2026 that GLP-1 medications, including Mounjaro, must add a warning about a possible increased risk of NAION, a rare optic nerve condition. Report sudden vision loss right away.12
Common side effects
Nausea, diarrhea, vomiting, constipation, indigestion and stomach pain, along with decreased appetite.
Pregnancy and other medicines
It is not known whether Mounjaro will harm an unborn baby, and it may pass into breast milk. Because it slows stomach emptying, it can change how medicines taken by mouth are absorbed, including birth control pills.11
Compounded tirzepatide is not Mounjaro and is not FDA-approved. This is not all of the safety information. Lilly’s Prescribing Information and Medication Guide have the rest. Side effects can be reported to the FDA at 1-800-FDA-1088.
Sources
- U.S. Food and Drug Administration. FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes. May 13, 2022. https://content.govdelivery.com/accounts/USFDA/bulletins/317b871
- Mounjaro (tirzepatide) Prescribing Information. Eli Lilly and Company. Revised 08/2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
- Eli Lilly and Company. Mounjaro savings and support, with Savings Card terms. https://mounjaro.lilly.com/savings-resources
- Garvey WT, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. https://pubmed.ncbi.nlm.nih.gov/37385275/
- Zepbound (tirzepatide) Prescribing Information. Eli Lilly and Company. Revised 08/2026. https://pi.lilly.com/us/zepbound-uspi.pdf
- U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- KFF. 2026 Employer Health Benefits Survey. https://www.kff.org/health-costs/2026-employer-health-benefits-survey/
- Frías JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385(6):503-515. https://pubmed.ncbi.nlm.nih.gov/34170647/
- Nicholls SJ, et al. Cardiovascular outcomes with tirzepatide versus dulaglutide in type 2 diabetes (SURPASS-CVOT). N Engl J Med. 2025;393(24):2409-2420. https://pubmed.ncbi.nlm.nih.gov/41406444/
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
- Mounjaro (tirzepatide) Medication Guide. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/mounjaro-us-mg.pdf
- U.S. Food and Drug Administration. FDA Requires Safety Labeling Changes for GLP-1 Receptor Agonists Due to Potential Increased Risk of Rare But Serious Eye Condition. November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
- Eli Lilly and Company. Mounjaro through LillyDirect. https://www.lilly.com/lillydirect/medicines/mounjaro
- Eli Lilly and Company. Mounjaro list price. https://pricinginfo.lilly.com/mounjaro
- Eli Lilly and Company. Zepbound through LillyDirect. https://www.lilly.com/lillydirect/zepbound
- KFF. Medicaid Coverage of and Spending on GLP-1s. https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/
- Medicare.gov. Weight loss drugs (Medicare GLP-1 Bridge). https://www.medicare.gov/glp1bridge
- Ozempic (semaglutide) Prescribing Information. Novo Nordisk. Revised 05/2026. https://www.novo-pi.com/ozempic.pdf
- Wegovy (semaglutide) Prescribing Information. Novo Nordisk. Revised 06/2026. https://www.novo-pi.com/wegovy.pdf
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Novo Nordisk. Ozempic cost and savings. https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
- Novo Nordisk. Wegovy cost and savings (NovoCare). https://www.novocare.com/obesity/products/wegovy/let-us-help/explaining-list-price.html
Web sources accessed November 18, 2026. Reviewed by the Zealthy care team.
Find out whether Mounjaro is the right fit
Complete the online intake and a licensed provider will review it. Your first month of membership is $39, and medication is separate.
Get Started